Hedge Fund - Great Point Partners
Kalvista Pharmaceuticals Inc. (KALV)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2025 - Q1 (2025-03-31) | $11,705,795 | 6.2% | 1,014,367 | $10.21 |
2 | 2024 - Q4 (2024-12-31) | $15,135,915 | 7.13% | 1,787,003 | $10.36 |
3 | 2024 - Q3 (2024-09-30) | $15,048,245 | 4.42% | 1,299,503 | $12.58 |
4 | 2024 - Q2 (2024-06-30) | $15,768,331 | 3.02% | 1,338,568 | $11.67 |
5 | 2023 - Q2 (2023-06-30) | $0 | 0% | 0 | $9.22 |
6 | 2023 - Q1 (2023-03-31) | $12,580,284 | 2.47% | 1,600,545 | $7.46 |
7 | 2022 - Q4 (2022-12-31) | $7,137,215 | 1.39% | 1,055,801 | $5.36 |
8 | 2022 - Q3 (2022-09-30) | $22,515,000 | 5.42% | 1,551,719 | $13.98 |
9 | 2022 - Q2 (2022-06-30) | $15,055,000 | 3.61% | 1,530,000 | $11.03 |
10 | 2022 - Q1 (2022-03-31) | $12,886,000 | 3.11% | 874,197 | $14.37 |
11 | 2021 - Q4 (2021-12-31) | $5,450,000 | 1.21% | 411,937 | $15.92 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
1.0000:14.0000 on 2016-11-22
-
1.0000:14.0000 on 2016-11-21